About Valcyte

Valcyte® (valganciclovir hydrochloride) is a cytomegalovirus (CMV) nucleoside analogue DNA polymerase inhibitor indicated in adult patients for the prevention of CMV disease in kidney, heart, or kidney-pancreas transplant patients at high risk (Donor CMV seropositive/Recipient CMV seronegative [D+/R−]), and for the treatment of CMV retinitis in patients with acquired immunodeficiency syndrome (AIDS).1

Valcyte is indicated in pediatric patients for the prevention of CMV disease in kidney or heart transplant patients at high risk (Donor CMV seropositive/Recipient CMV seronegative [D+/R−]).1

For each of these Valcyte patient populations, learn about: